Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Y Yakata

Effect of a Selective Abl Tyrosine Kinase Inhibitor, STI571, on in Vitro Growth of BCR-ABL-positive Acute Lymphoblastic Leukemia Cells

Cancer Research

English

Related publications

Tyrosine Kinase Inhibitors in BCR-ABL Positive Acute Lymphoblastic Leukemia

English

Inhibition of Phosphotyrosine Phosphatase 1B Causes Resistance in BCR-ABL-Positive Leukemia Cells to the ABL Kinase Inhibitor STI571

Clinical Cancer Research

Cancer Research

English

BCR-ABL Tyrosine Kinase

Science-Business eXchange

English

Treatment of BCR/Abl-Positive Acute Lymphoblastic Leukemia in P190 Transgenic Mice With the Farnesyl Transferase Inhibitor SCH66336

English

Immunologic Characterization of the Tumor-Specific BCR-Abl Junction in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

English

Purinostat Mesylate Is a Uniquely Potent and Selective Inhibitor of HDACs for the Treatment of BCR-ABL-induced B-Cell Acute Lymphoblastic Leukemia

Clinical Cancer Research

Cancer Research

English

Nilotinib Treatment in Mouse Models of P190 BCR/Abl Lymphoblastic Leukemia

Molecular Cancer

Cancer Research

Molecular Medicine

English

Differential Genomics and Transcriptomics Between Tyrosine Kinase Inhibitor-Sensitive and -Resistant BCR-ABL-dependent Chronic Myeloid Leukemia

English

Acute Myeloid Leukemia With BCR/ABL Fusion Chimera

Indian Journal of Hematology and Blood Transfusion

English